title: Unique sequences in the guinea pig glucocorticoid receptor induce constitutive transactivation and decrease steroid sensitivity.
abstract: Previous attempts to characterize the structural determinants required for binding of cortisol by the glucocorticoid receptor (GR) have proved difficult since almost all modifications of the ligand binding domain (LBD) of GRs either eliminate or greatly decrease steroid binding. The guinea pig, a New World hystricomorph with a phylogeny the subject of recent dispute, is corticoresistant due to a GR that has diminished affinity for dexamethasone. The guinea pig GR has been cloned, and sequencing has identified many unique amino acid substitutions in the LBD. Using a domain-swap approach, the cloned guinea pig GR LBD was substituted for the human GR LBD in a human GR expression vector. Dexamethasone response curves for these constructs show that the cortisol resistance observed in the guinea pig in vivo is conferred in vitro by the guinea pig GR LBD. In addition, the guinea pig GR LBD induces a high level of constitutive activity. This constitutive activity is not repressed by RU486 (1 microM) but is enhanced by the addition of 8-bromo-cAMP. One of the amino acid substitutions results in the loss of a cysteine, which in the human, rat, and mouse GR is the site of covalent attachment for dexamethasone-21-mesylate. This cysteine is replaced by a tryptophan residue in the guinea pig GR, the implications of which were examined by reciprocal mutation of the tryptophan to a cysteine in the guinea pig GR LBD, and the cysteine to a tryptophan in the human GR LBD.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Prince Henry's Institute of Medical Research Clayton, Australia.
authors.forename: M C
authors.initials: MC
authors.lastname: Keightley
authors.forename: P J
authors.initials: PJ
authors.lastname: Fuller
mesh_terms: D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D000595:Amino Acid Sequence; D000818:Animals; D003001:Cloning, Molecular; D003545:Cysteine; D003907:Dexamethasone / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology*; D004351:Drug Resistance; D005786:Gene Expression Regulation / Q000187:drug effects*; D005822:Genetic Vectors; D006168:Guinea Pigs / Q000378:metabolism*; D000882:Haplorhini; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism / Q000494:pharmacology; D051379:Mice; D015735:Mifepristone / Q000494:pharmacology; D008969:Molecular Sequence Data; D009154:Mutation; D010802:Phylogeny; D051381:Rats; D011965:Receptors, Glucocorticoid / Q000737:chemistry* / Q000187:drug effects / Q000502:physiology; D012377:Rodentia / Q000145:classification; D017386:Sequence Homology, Amino Acid; D013045:Species Specificity; D015533:Transcriptional Activation; D014364:Tryptophan
chemical_list: D011965:Receptors, Glucocorticoid; C028697:dexamethasone receptor; D015124:8-Bromo Cyclic Adenosine Monophosphate; D015735:Mifepristone; D003907:Dexamethasone; D014364:Tryptophan; D003545:Cysteine; C031710:dexamethasone 21-methanesulfonate; D006854:Hydrocortisone